Rate My Professor Haiden Huskamp

Dr. Huskamp's primary research interests are mental health and substance use disorder policy, prescription drug policy, and the financing and utilization of end-of-life care services. She serves as Director of Harvard’s NIMH T32 Pre- and Post-doctoral Training Program in Mental Health Policy and Co-director of the Brandeis/Harvard SPIRE Center, a NIDA-funded P30 center. As Multi-Principal Investigator, she leads R01 grants from NIDA on telemedicine for opioid use disorder, NIMH on telemedicine for mental illness, and NIAAA on medications for alcohol use disorder. Major awards include the Robert Wood Johnson Foundation Investigator Award in Health Policy Research (2007-2011), National Institute of Mental Health Career Development Award (2002-2007), and Barbara J. McNeil Faculty Award for Exceptional Institutional Service (2017). Key publications feature “Use of Telemedicine and Quality of Care Among Medicare Enrollees With Serious Mental Illness” (JAMA Health Forum, 2023), “Strategies To Treat Opioid Use Disorder” (Health Affairs, 2023), “Disruptions in Care for Medicare Beneficiaries With Severe Mental Illness During the COVID-19 Pandemic” (JAMA Network Open, 2022), and “Mental Health and Substance-Use Reforms – Milestones Reached, Challenges Ahead” (New England Journal of Medicine, 2016). She has served on multiple National Academy of Medicine committees, such as the Committee on Developing Evidence-Based Standards for Psychosocial Interventions for Mental Disorders and the Roundtable on Quality Care for People with Serious Illness.